The new SARS-CoV-2 contaminations responsible for Covid-19 are soaring like never before since the start of the epidemic, with at least 23,621 new cases detected on Monday, November 22. This is the absolute record of coronavirus contaminations in one day ever recorded in Belgium, even at the height of the first two waves.
The Consultative Committee deemed the situation delicate enough to meet this Friday. He should announce new measures where vaccination will remain a trump card: the federal governments and federated entities should accelerate the tempo for the booster (2nd dose Johnson & Johnson and 3rd dose for other vaccines) and the first dose in children between 5 and 11 years old.
A note is circulating among the members of the executives about the vaccination. From a good source, it should be discussed earlier than expected, that is to say this Friday, in the Concertation Committee. Initially, it proposed an organization of vaccination for the next few months and was accompanied by a calendar (see table above).
►►► To read: More than 23,500 cases detected on Monday, November 22, an absolute record since the start of the epidemic
This calendar should logically be validated this Saturday at an interministerial conference of health ministers. The consultation committee is preparing to ask for the “fastest possible” implementation of this vaccination plan. Objective: to try to accelerate given the evolution of the Covid-19 epidemic.
1st dose for 5-11 year olds
Regarding young children, Federal Minister of Health Frank Vandenbroucke said he was waiting for the green light from the European Medicines Agency to administer Comirnaty, the Pfizer-BioNTech vaccine, to 5-11 year olds. This has been done since yesterday, the EMA also specifying that the dose administered would be less dosed compared to the vaccine for adults, but that it would have the same effectiveness.
►►► Read: European Medicines Agency clears Pfizer-BioNTech vaccine for 5-11 year olds
She would be inoculated in two doses, three weeks apart. The Pfizer-BioNTech vaccine would thus become the first to be administered to young children in Belgium, after having been authorized in the United States and in Israel.
In the note we obtained, vaccination of 5-11 year olds is scheduled between the end of December and mid-April (see table).
The campaign linked to the booster is already well underway since people with co-morbidities, those over 65, residents of nursing homes, caregivers or people who have received a dose of the Johnson & Johnson vaccine have already been invited to do so. vaccinate.
In the note on the table of the Consultative Committee, after people vaccinated with Johnson & Johnson, it is the turn of those vaccinated with AstraZeneca to be offered the booster in early December. All other people (4,800,000 people) would be invited to receive the booster from mid-December.
Still according to the note we have obtained, the stocks will be sufficient to organize the “booster” campaign with a messenger RNA vaccine (Pfizer-BioNTech or Moderna) and the vaccination capacities should increase again (vaccination centers in particular) until next April. Pharmacists could be more involved in this campaign.
The population vaccination schedule should be discussed this Friday in the Consultation Committee and perhaps anticipated. Tracing should also be strengthened and new measures announced.